Galera shareholders approve reverse split (1:75 to 1:200) and share increase to 400M

Galera Therapeutics, Inc.

• Elected J. Mel Sorensen (Class III), Nancy Chang and Michael Friedman (Class I) as directors.
• Ratified KPMG as auditor for FY 2026.
• Approved say-on-pay and annual frequency for future say-on-pay votes.
• Authorized amendment raising common shares from 200M to 400M.
• Authorized reverse stock split at Board-discretion ratio between 1:75 and 1:200.

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.